TYMS and cancer: Gong et al. found that cobimetinib not only inhibited CRC cell proliferation but also induced G1 phase arrest and apoptosis in cancer cells; in addition, cobimetinib appeared to enhance the efficacy of 5-Fluorouracil (5-FU) by reducing TYMS expression [72].